Key Financial Data Of Reporting Company

Fuji Pharma Co.,Ltd. - Filing #7339242

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-10-01 to
2024-03-31
As at
2023-09-30
2022-10-01 to
2023-09-30
2023-01-01 to
2023-03-31
As at
2023-03-31
2022-10-01 to
2023-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
21,388,000,000 JPY
40,889,000,000 JPY
19,225,000,000 JPY
Ordinary profit (loss)
2,165,000,000 JPY
4,519,000,000 JPY
2,456,000,000 JPY
Net assets
44,066,000,000 JPY
41,177,000,000 JPY
40,452,000,000 JPY
Total assets
85,006,000,000 JPY
85,332,000,000 JPY
84,803,000,000 JPY
Basic earnings (loss) per share
62.43
175.15
141.37
27.07
72.95
Diluted earnings per share
Equity-to-asset ratio
0.518 xbrli:pure
0.483 xbrli:pure
0.477 xbrli:pure
Net cash provided by (used in) operating activities
-445,000,000 JPY
1,917,000,000 JPY
1,516,000,000 JPY
Net cash provided by (used in) investing activities
1,457,000,000 JPY
-5,240,000,000 JPY
-2,872,000,000 JPY
Net cash provided by (used in) financing activities
-1,998,000,000 JPY
1,915,000,000 JPY
3,058,000,000 JPY
Cash and cash equivalents
1,375,000,000 JPY
2,324,000,000 JPY
5,282,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.